Diseases Starting with R
BioSniper tracks 1,082 diseases and indications whose names begin with R — each with drugs in development by phase, sponsoring companies, and active clinical trials. Updated hourly.
- r-axSpA1 trials
- R/R AML1 trials
- R/R CD19-Positive B-Cell Malignancies1 trials
- R/R HR-MDS1 trials
- Rabies4 trials
- Rabies (Healthy Volunteers)6 trials
- Rabies Human1 trials
- Rabies Post-exposure Prophylaxis1 trials
- Rabies Virus Infection1 trials
- Radiation Cystitis1 trials
- Radiation Dermatitis1 trials
- Radiation Induced Fibrosis1 trials
- Radiation Induced Lung Injury (RILI)1 trials
- Radiation Proctopathy1 trials
- Radiation Retinopathy1 trials
- Radiation Therapy3 trials
- Radiation-induced Dermatitis1 trials
- Radiation-induced Lung Injury1 trials
- Radiation-induced Oral Mucositis2 trials
- Radiation-Induced Xerostomia1 trials
- Radical Cystectomy1 trials
- Radical Prostatectomy
- Radiculopathy1 trials
- Radiculopathy Lumbar1 trials
- Radiofrequency Catheter Ablation1 trials
- Radiographic Axial Spondyloarthritis1 trials
- Radiological Outcomes1 trials
- Radiology1 trials
- Radiopharmaceutical1 trials
- Radiostereometric Analysis1 trials
- Radiotherapy6 trials
- Radiotherapy Side Effect1 trials
- Radiotherapy Side Effects1 trials
- Radiotherapy-induced Oral Mucositis1 trials
- Radiotherapy-Induced Oral Mucositis1 trials
- Radiotherapy; Adverse Effect1 trials
- Radiotherapy; Complications1 trials
- Radiotracer1 trials
- RAF Mutation4 trials
- RAF1 Fusion1 trials
- RAF1 Gene Amplification1 trials
- RAF1 Gene Fusion1 trials
- Randomized Controlled Trial3 trials
- Randomized Controlled Trial (RCT)1 trials
- Rapid Sequence Intubation1 trials
- Rapide Sequence Induction1 trials
- Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma1 trials
- Rare Ataxia1 trials
- Rare Bleeding Disorder1 trials
- Rare Cancer3 trials
- Rare Cancers2 trials
- Rare CNS Tumor Recurrent1 trials
- Rare Diseases8 trials
- Rare Disorder2 trials
- Rare Disorders2 trials
- Rare Gastrointestinal Disorders1 trials
- Rare Genetic Disease1 trials
- Rare Genetic Disorders1 trials
- Rare Hereditary Ataxia1 trials
- Rare Inflammatory Bowel Disease1 trials
- Rare Retinal Disorder1 trials
- Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors1 trials
- Ras (Kras or Nras) Gene Mutation1 trials
- RAS G12D-mutated NSCLC1 trials
- RAS Mutation7 trials
- RAS Pathway1 trials
- RAS Wild Type Colorectal Cancer1 trials
- Ras-mutated Metastatic Colorectal Cancer1 trials
- RAS/BRAF Wild Type Colorectal Cancer1 trials
- RAS/BRAF Wild-type Advanced Colorectal Cancer Patients1 trials
- Ras/MAPK Pathway Vascular Anomalies1 trials
- Rash Due to Epidermal Growth Factor Receptor Inhibitors1 trials
- Rate Control1 trials
- Rate of CKD Diagnosis in Patients With AH and CKD Markers1 trials
- Raynaud Phenomenon1 trials
- Raynaud's Phenomenon Secondary to Systemic Sclerosis1 trials
- RCC2 trials
- RCC, Clear Cell Adenocarcinoma1 trials
- RDEB1 trials
- Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance1 trials
- Real-World Data1 trials
- Rebound Hyperbilirubinemia1 trials
- Recalcitrant Infectious Keratitis1 trials
- Recent-Onset Psychosis1 trials
- Receptor Tyrosine Kinase Gene Mutation1 trials
- Receptors, Cell Surface1 trials
- Receptors, G-Protein-Coupled1 trials
- Receptors, Peptide1 trials
- Recessive Dystrophic Epidermolysis Bullosa4 trials
- Recessive Dystrophic Epidermolysis Bullosa (RDEB)1 trials
- Recessive Mitochondrial Ataxia Syndrome1 trials
- Reconstruction Surgeries of the Foot
- Reconstructive Surgical Procedures1 trials
- Recovery2 trials
- Recovery After Total Hip Arthroplasty1 trials
- Recovery Time1 trials
- Recruitment1 trials
- Rectal Adenocarcinoma9 trials
- Rectal Cancer22 trials
- Rectal Cancer Recurrent1 trials
- Rectal Cancer Stage II1 trials
- Rectal Cancer Stage III1 trials
- Rectal Cancer Stage IV1 trials
- Rectal Cancer, Adenocarcinoma1 trials
- Rectal Cancer, Metastatic1 trials
- Rectal Carcinoma3 trials
- Rectal Melanoma1 trials
- Rectal Neuroendocrine Tumors1 trials
- Rectal Squamous Cell Carcinoma1 trials
- Rectovaginal Fistula1 trials
- Rectum Cancer1 trials
- Rectum Diameter1 trials
- Recurrence1 trials
- Recurrence of Chronic Bacterial Cystitis1 trials
- Recurrent3 trials
- Recurrent Acute Leukemia of Ambiguous Lineage1 trials
- Recurrent Acute Lymphoblastic Leukemia6 trials
- Recurrent Acute Myeloid Leukemia13 trials
- Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage1 trials
- Recurrent Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged1 trials
- Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia1 trials
- Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes1 trials
- Recurrent Acute Pancreatitis2 trials
- Recurrent Adenoid Cystic Carcinoma1 trials
- Recurrent Adrenal Cortical Carcinoma1 trials
- Recurrent Adult Acute Myeloid Leukemia2 trials
- Recurrent Adult Brain Neoplasm1 trials
- Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant
- Recurrent Adult Diffuse Large Cell Lymphoma1 trials
- Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant
- Recurrent Adult Hodgkin's Lymphoma
- Recurrent Adult Lymphoblastic Lymphoma1 trials
- Recurrent Adult Soft Tissue Sarcoma1 trials
- Recurrent Adult T-Cell Leukemia/Lymphoma1 trials
- Recurrent Anal Squamous Cell Carcinoma
- Recurrent Anaplastic Large Cell Lymphoma2 trials
- Recurrent Angioimmunoblastic T-Cell Lymphoma1 trials
- Recurrent Aphtous Stomatitis1 trials
- Recurrent Astrocytoma1 trials
- Recurrent Astrocytoma, IDH-Mutant
- Recurrent Astrocytoma, IDH-Mutant, Grade 3
- Recurrent Astrocytoma, IDH-Mutant, Grade 4
- Recurrent Atypical Chronic Myeloid Leukemia1 trials
- Recurrent Atypical Teratoid/Rhabdoid Tumor1 trials
- Recurrent B Acute Lymphoblastic Leukemia5 trials
- Recurrent B Lymphoblastic Lymphoma2 trials
- Recurrent B-Cell Non-Hodgkin Lymphoma3 trials
- Recurrent Basal Cell Carcinoma1 trials
- Recurrent Biliary Tract Carcinoma1 trials
- Recurrent Bladder Carcinoma1 trials
- Recurrent Bladder Urothelial Carcinoma
- Recurrent Brain Metastases2 trials
- Recurrent Breast Cancer6 trials
- Recurrent Breast Carcinoma10 trials
- Recurrent Burkitt Leukemia
- Recurrent Burkitt Lymphoma
- Recurrent Cancer6 trials
- Recurrent Castration-Sensitive Prostate Carcinoma1 trials
- Recurrent Catheter-associated UTI (CAUTI)1 trials
- Recurrent Central Nervous System Lymphoma1 trials
- Recurrent Cervical Cancer
- Recurrent Cervical Carcinoma3 trials
- Recurrent Cervix Cancer
- Recurrent Childhood Acute Myeloid Leukemia1 trials
- Recurrent Childhood Fibrolamellar Carcinoma1 trials
- Recurrent Childhood Lymphoblastic Lymphoma
- Recurrent Childhood Malignant Solid Neoplasm1 trials
- Recurrent Childhood Myelodysplastic Syndrome1 trials
- Recurrent Childhood Soft Tissue Sarcoma1 trials
- Recurrent Cholangiocarcinoma1 trials
- Recurrent Chordoma1 trials
- Recurrent Chronic Lymphocytic Leukemia5 trials
- Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma1 trials
- Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive1 trials
- Recurrent Chronic Myelomonocytic Leukemia2 trials
- Recurrent Classic Hodgkin Lymphoma1 trials
- Recurrent Clostridioides Difficile Infection1 trials
- Recurrent Clostridium Difficile Infection1 trials
- Recurrent Colon Carcinoma1 trials
- Recurrent Colorectal Adenocarcinoma1 trials
- Recurrent Colorectal Carcinoma4 trials
- Recurrent Craniopharyngioma1 trials
- Recurrent Cutaneous Melanoma2 trials
- Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma1 trials
- Recurrent Depressive Disorder, Current Episode Moderate1 trials
- Recurrent Depressive Disorder, Current Episode Severe Without Psychotic Symptoms1 trials
- Recurrent Desmoid Fibromatosis1 trials
- Recurrent Differentiated Thyroid Gland Carcinoma2 trials
- Recurrent Diffuse Intrinsic Pontine Glioma1 trials
- Recurrent Diffuse Large B-Cell Lymphoma15 trials
- Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified2 trials
- Recurrent Diffuse Midline Glioma, H3 K27M-Mutant1 trials
- Recurrent Digestive System Carcinoma1 trials
- Recurrent Endometrial Cancer2 trials
- Recurrent Endometrial Carcinoma6 trials
- Recurrent Endometrial Endometrioid Adenocarcinoma2 trials
- Recurrent Endometrial Serous Adenocarcinoma1 trials
- Recurrent Enteropathy-Associated T-Cell Lymphoma2 trials
- Recurrent Ependymoma1 trials
- Recurrent Epithelial Ovarian Cancer1 trials
- Recurrent Epithelioid Sarcoma1 trials
- Recurrent Esophageal Carcinoma1 trials
- Recurrent Ewing Sarcoma1 trials
- Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue1 trials
- Recurrent Extrapulmonary Neuroendocrine Carcinoma
- Recurrent Fallopian Tube Cancer2 trials
- Recurrent Fallopian Tube Carcinoma10 trials
- Recurrent Fallopian Tube Endometrioid Adenocarcinoma1 trials
- Recurrent Fallopian Tube Serous Adenocarcinoma1 trials
- Recurrent Female Reproductive System Carcinoma1 trials
- Recurrent Fibrolamellar Carcinoma1 trials
- Recurrent Follicular Helper T-Cell Lymphoma1 trials
- Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type1 trials
- Recurrent Follicular Helper T-Cell Lymphoma, Follicular-Type1 trials
- Recurrent Follicular Helper T-Cell Lymphoma, Not Otherwise Specified1 trials
- Recurrent Follicular Lymphoma7 trials
- Recurrent Gallbladder Carcinoma2 trials
- Recurrent Gastric Carcinoma1 trials
- Recurrent Genital Herpes Simplex Type 22 trials
- Recurrent Glioblastoma18 trials
- Recurrent Glioblastoma IDH Wildtype1 trials
- Recurrent Glioblastoma Multiforme1 trials
- Recurrent Glioblastoma, IDH-Wildtype2 trials
- Recurrent Glioma2 trials
- Recurrent Gliomas1 trials
- Recurrent Gliosarcoma1 trials
- Recurrent Grade 1 Follicular Lymphoma2 trials
- Recurrent Grade 2 Follicular Lymphoma2 trials
- Recurrent Grade 3 Follicular Lymphoma2 trials
- Recurrent Grade 3a Follicular Lymphoma1 trials
- Recurrent Grade 3b Follicular Lymphoma5 trials
- Recurrent Group 3 Medulloblastoma1 trials
- Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma1 trials
- Recurrent Head and Neck Cancer6 trials
- Recurrent Head and Neck Carcinoma3 trials
- Recurrent Head and Neck Squamous Cell Carcinoma12 trials
- Recurrent Hematologic Cancer1 trials
- Recurrent Hepatoblastoma1 trials
- Recurrent Hepatocellular Carcinoma4 trials
- Recurrent Hepatosplenic T-Cell Lymphoma2 trials
- Recurrent High Grade B-Cell Lymphoma3 trials
- Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements2 trials
- Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements1 trials
- Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified1 trials
- Recurrent High Risk Myelodysplastic Syndrome2 trials
- Recurrent High-grade Glioma1 trials
- Recurrent Histiocytic and Dendritic Cell Neoplasm1 trials
- Recurrent Hodgkin Lymphoma4 trials
- Recurrent Hypopharyngeal Squamous Cell Carcinoma3 trials
- Recurrent Intrahepatic Cholangiocarcinoma2 trials
- Recurrent Islet Cell Carcinoma1 trials
- Recurrent Juvenile Myelomonocytic Leukemia1 trials
- Recurrent Kaposi Sarcoma1 trials
- Recurrent Kidney Medullary Carcinoma1 trials
- Recurrent Langerhans Cell Histiocytosis
- Recurrent Laryngeal Nerve Injury1 trials
- Recurrent Laryngeal Squamous Cell Carcinoma3 trials
- Recurrent Lip and Oral Cavity Squamous Cell Carcinoma1 trials
- Recurrent Liver Carcinoma1 trials
- Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma1 trials
- Recurrent Low-Grade Glioma1 trials
- Recurrent Lung Cancer2 trials
- Recurrent Lung Carcinoma1 trials
- Recurrent Lung Neuroendocrine Neoplasm1 trials
- Recurrent Lung Non-Small Cell Carcinoma10 trials
- Recurrent Lung Non-Squamous Non-Small Cell Carcinoma1 trials
- Recurrent Lung Small Cell Carcinoma2 trials
- Recurrent Lymphoma2 trials
- Recurrent Lymphoplasmacytic Lymphoma1 trials
- Recurrent Male Reproductive System Carcinoma1 trials
- Recurrent Malignant Brain Neoplasm1 trials
- Recurrent Malignant Central Nervous System Neoplasm1 trials
- Recurrent Malignant Female Reproductive System Neoplasm2 trials
- Recurrent Malignant Germ Cell Tumor1 trials
- Recurrent Malignant Neoplasm2 trials
- Recurrent Malignant Solid Neoplasm11 trials
- Recurrent Malignant Uterine Corpus Neoplasm1 trials
- Recurrent Mantle Cell Lymphoma9 trials
- Recurrent Marginal Zone Lymphoma3 trials
- Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma1 trials
- Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma1 trials
- Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma2 trials
- Recurrent Medulloblastoma1 trials
- Recurrent Melanoma5 trials
- Recurrent Melanoma (Skin)1 trials
- Recurrent Meningioma4 trials
- Recurrent MGMT-Methylated Glioblastoma1 trials
- Recurrent Mixed Phenotype Acute Leukemia2 trials
- Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma2 trials
- Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder1 trials
- Recurrent Mucosal Melanoma1 trials
- Recurrent Multiple Myeloma9 trials
- Recurrent Mycosis Fungoides2 trials
- Recurrent Myelodysplastic Syndrome4 trials
- Recurrent Myelodysplastic Syndrome/Acute Myeloid Leukemia
- Recurrent Myelodysplastic/Myeloproliferative Neoplasm2 trials
- Recurrent Myeloid Sarcoma1 trials
- Recurrent Myeloproliferative Neoplasm1 trials
- Recurrent Nasopharyngeal Carcinoma3 trials
- Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma1 trials
- Recurrent Nasopharyngeal Squamous Cell Carcinoma1 trials
- Recurrent Nasopharyngeal Undifferentiated Carcinoma1 trials
- Recurrent Nasopharynx Carcinoma
- Recurrent Neck Squamous Cell Carcinoma of Unknown Primary1 trials
- Recurrent Neuroblastoma2 trials
- Recurrent Nodal Marginal Zone Lymphoma1 trials
- Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma1 trials
- Recurrent Non-catheter Associated UTIs1 trials
- Recurrent Non-Hodgkin Lymphoma4 trials
- Recurrent Non-Muscle Invasive Bladder Carcinoma1 trials
- Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma1 trials
- Recurrent Non-small Cell Lung Cancer1 trials
- Recurrent Non-Small Cell Lung Carcinoma3 trials
- Recurrent NSCLC2 trials
- Recurrent or Metastatic Breast Cancer2 trials
- Recurrent or Metastatic Esophageal Adenocarcinoma1 trials
- Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma1 trials
- Recurrent or Metastatic Nasopharyngeal Carcinoma
- Recurrent or Metastatic Solid Tumors2 trials
- Recurrent or Metastatic Vulvar Cancer1 trials
- Recurrent or Progressive Endometrial Cancer1 trials
- Recurrent or Refractory Disease After Standard Therapies2 trials
- Recurrent or Unresectable Central Nervous System (CNS) Tumors
- Recurrent Oral Cavity Squamous Cell Carcinoma2 trials
- Recurrent Oropharyngeal Squamous Cell Carcinoma2 trials
- Recurrent Osteosarcoma4 trials
- Recurrent Ovarian1 trials
- Recurrent Ovarian Cancer5 trials
- Recurrent Ovarian Carcinoma13 trials
- Recurrent Ovarian Clear Cell Adenocarcinoma2 trials
- Recurrent Ovarian Endometrioid Adenocarcinoma3 trials
- Recurrent Ovarian High Grade Serous Adenocarcinoma1 trials
- Recurrent Ovarian Low Grade Serous Adenocarcinoma1 trials
- Recurrent Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor1 trials
- Recurrent Ovarian Mucinous Adenocarcinoma1 trials
- Recurrent Ovarian Serous Adenocarcinoma1 trials
- Recurrent Ovarian Transitional Cell Carcinoma1 trials
- Recurrent Ovary Cancer2 trials
- Recurrent Pancreatic Carcinoma4 trials
- Recurrent Paranasal Sinus Squamous Cell Carcinoma
- Recurrent Pericarditis5 trials
- Recurrent Peripheral Primitive Neuroectodermal Tumor1 trials
- Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified2 trials
- Recurrent Peritoneal Cancer1 trials
- Recurrent Pharyngeal Carcinoma1 trials
- Recurrent Pharyngeal Squamous Cell Carcinoma1 trials
- Recurrent Plasma Cell Myeloma6 trials
- Recurrent Platinum-Resistant Fallopian Tube Carcinoma1 trials
- Recurrent Platinum-Resistant Ovarian Carcinoma3 trials
- Recurrent Platinum-Resistant Primary Peritoneal Carcinoma1 trials
- Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder1 trials
- Recurrent Pregnancy Loss1 trials
- Recurrent Primary Amyloidosis2 trials
- Recurrent Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma1 trials
- Recurrent Primary Cutaneous Gamma-Delta T-Cell Lymphoma1 trials
- Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma1 trials
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma1 trials
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma2 trials
- Recurrent Primary Mediastinal Large B-Cell Lymphoma3 trials
- Recurrent Primary Peritoneal Cancer1 trials
- Recurrent Primary Peritoneal Carcinoma10 trials
- Recurrent Primary Peritoneal Clear Cell Adenocarcinoma1 trials
- Recurrent Primary Peritoneal Endometrioid Adenocarcinoma1 trials
- Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma1 trials
- Recurrent Primary Peritoneal Serous Adenocarcinoma1 trials
- Recurrent Prostate Adenocarcinoma1 trials
- Recurrent Prostate Cancer9 trials
- Recurrent Prostate Carcinoma12 trials
- Recurrent Rectal Carcinoma1 trials
- Recurrent Renal Cell Carcinoma3 trials
- Recurrent Renal Pelvis Urothelial Carcinoma
- Recurrent Respiratory Papillomatosis4 trials
- Recurrent Rhabdoid Tumor2 trials
- Recurrent Rhabdomyosarcoma1 trials
- Recurrent Salivary Gland Cancer
- Recurrent Salivary Gland Carcinoma1 trials
- Recurrent Sarcoma1 trials
- Recurrent Secondary Acute Myeloid Leukemia1 trials
- Recurrent Severe Aplastic Anemia1 trials
- Recurrent Sinonasal Squamous Cell Carcinoma1 trials
- Recurrent Skin Carcinoma1 trials
- Recurrent Small Lymphocytic Lymphoma5 trials
- Recurrent Soft Tissue Sarcoma1 trials
- Recurrent Soft Tissue Sarcoma of the Trunk and Extremities1 trials
- Recurrent Solid Tumor3 trials
- Recurrent Splenic Marginal Zone Lymphoma1 trials
- Recurrent Squamous Cell Carcinoma1 trials
- Recurrent Squamous Cell Carcinoma of the Head and Neck2 trials
- Recurrent Squamous Cell Lung Carcinoma1 trials
- Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma1 trials
- Recurrent T Acute Lymphoblastic Leukemia1 trials
- Recurrent T Lymphoblastic Lymphoma1 trials
- Recurrent T-Cell Non-Hodgkin Lymphoma1 trials
- Recurrent Thyroid Gland Carcinoma3 trials
- Recurrent Thyroid Gland Follicular Carcinoma1 trials
- Recurrent Thyroid Gland Medullary Carcinoma1 trials
- Recurrent Thyroid Gland Papillary Carcinoma1 trials
- Recurrent Transformed B-Cell Non-Hodgkin Lymphoma4 trials
- Recurrent Transformed Chronic Lymphocytic Leukemia5 trials
- Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma1 trials
- Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma2 trials
- Recurrent Transformed Non-Hodgkin Lymphoma3 trials
- Recurrent Triple-Negative Breast Cancer1 trials
- Recurrent Triple-Negative Breast Carcinoma1 trials
- Recurrent Ureter Urothelial Carcinoma
- Recurrent Urethral Urothelial Carcinoma
- Recurrent Urinary Tract Infection1 trials
- Recurrent Urothelial Carcinoma1 trials
- Recurrent Uterine Corpus Carcinoma1 trials
- Recurrent UTIs1 trials
- Recurrent Uveal Melanoma1 trials
- Recurrent Ventricular Tachycardia1 trials
- Recurrent Viral Meningitis1 trials
- Recurrent Vulvovaginal Candidiasis
- Recurrent WHO Grade 2 Glioma
- Recurrent WHO Grade 3 Glioma
- Recurrent WHO Grade 4 Glioma1 trials
- Recurrent WHO Grade III Glioma1 trials
- Recurrent Wilms Tumor1 trials
- Recurrent World Health Organization (WHO) Grade II Glioma1 trials
- Recurrent/ Metastatic Olfactory Neuroblastoma1 trials
- Recurrent/Metastatic Head and Neck Cancer1 trials
- Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma1 trials
- Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
- Reduced Ejection Fraction Heart Failure1 trials
- Reduction in the Initial Length of Stay1 trials
- Referral and Consultation1 trials
- Referred Pain1 trials
- Reflexology1 trials
- Reflux Episodes1 trials
- Reflux Esophagitis2 trials
- Refractive Error3 trials
- Refractory4 trials
- Refractory / Relapsed / Progressive Systemic Sclerosis1 trials
- Refractory / Relapsed Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis1 trials
- Refractory / Relapsed Connective Tissue Disease-Associated Thrombocytopenia1 trials
- Refractory / Relapsing / Progressive Inflammatory Myopathy1 trials
- Refractory Acute Biphenotypic Leukemia1 trials
- Refractory Acute Leukemia1 trials
- Refractory Acute Leukemia of Ambiguous Lineage2 trials
- Refractory Acute Lymphoblastic Leukemia9 trials
- Refractory Acute Lymphoblastic Leukemia (ALL)2 trials
- Refractory Acute Lymphoid Leukemia1 trials
- Refractory Acute Lymphoid Leukemia in Relapse1 trials
- Refractory Acute Myelogenous Leukemia (AML)1 trials
- Refractory Acute Myeloid Leukemia20 trials
- Refractory Acute Myeloid Leukemia (AML)
- Refractory Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage1 trials
- Refractory Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged1 trials
- Refractory Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia1 trials
- Refractory Adult T-Cell Leukemia/Lymphoma1 trials
- Refractory AL Amyloidosis2 trials
- Refractory AML1 trials
- Refractory Anaplastic Large Cell Lymphoma3 trials
- Refractory Anemia2 trials
- Refractory Angioimmunoblastic T-Cell Lymphoma1 trials
- Refractory Atypical Teratoid/Rhabdoid Tumor1 trials
- Refractory Autoimmune Diseases1 trials
- Refractory B Acute Lymphoblastic Leukemia3 trials
- Refractory B Lymphoblastic Lymphoma2 trials
- Refractory B-Cell NHL1 trials
- Refractory B-cell Non-Hodgkin Lymphoma1 trials
- Refractory B-Cell Non-Hodgkin Lymphoma7 trials
- Refractory B-Cell Small Lymphocytic Lymphoma1 trials
- Refractory Biphenotypic Leukemia1 trials
- Refractory Bladder Urothelial Carcinoma1 trials
- Refractory Burkitt Leukemia
- Refractory Burkitt Lymphoma
- Refractory Cancer11 trials
- Refractory Central Nervous System Lymphoma1 trials
- Refractory Childhood Acute Myeloid Leukemia1 trials
- Refractory Childhood Fibrolamellar Carcinoma1 trials
- Refractory Childhood Malignant Solid Neoplasm1 trials
- Refractory Childhood Myelodysplastic Syndrome1 trials
- Refractory Chordoma1 trials
- Refractory Chronic Cough4 trials
- Refractory Chronic Lymphocytic Leukemia8 trials
- Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma2 trials
- Refractory Chronic Myelomonocytic Leukemia4 trials
- Refractory Classic Hodgkin Lymphoma2 trials
- Refractory Colorectal Adenocarcinoma2 trials
- Refractory Constipation1 trials
- Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma1 trials
- Refractory Differentiated Thyroid Gland Carcinoma2 trials
- Refractory Diffuse Large B Cell Lymphoma1 trials
- Refractory Diffuse Large B Cell Lymphoma (DLBCL)1 trials
- Refractory Diffuse Large B-cell Lymphoma3 trials
- Refractory Diffuse Large B-Cell Lymphoma16 trials
- Refractory Diffuse Large B-cell Lymphoma (DLBCL)1 trials
- Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified2 trials
- Refractory Endometrial Adenocarcinoma1 trials
- Refractory Endometrial Carcinoma3 trials
- Refractory Endometrial Clear Cell Adenocarcinoma1 trials
- Refractory Endometrial Endometrioid Adenocarcinoma2 trials
- Refractory Endometrial Mixed Cell Adenocarcinoma1 trials
- Refractory Endometrial Serous Adenocarcinoma1 trials
- Refractory Endometrial Undifferentiated Carcinoma1 trials
- Refractory Enteropathy-Associated T-Cell Lymphoma2 trials
- Refractory Epilepsy1 trials
- Refractory Epithelioid Sarcoma1 trials
- Refractory Ewing Sarcoma2 trials
- Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue1 trials
- Refractory Fallopian Tube Carcinoma1 trials
- Refractory Fibrolamellar Carcinoma1 trials
- Refractory Focal Epilepsy1 trials
- Refractory Follicular Helper T-Cell Lymphoma1 trials
- Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type1 trials
- Refractory Follicular Helper T-Cell Lymphoma, Follicular-Type1 trials
- Refractory Follicular Helper T-Cell Lymphoma, Not Otherwise Specified1 trials
- Refractory Follicular Lymphoma10 trials
- Refractory Gastroesophageal Reflux Disease1 trials
- Refractory Germ-cell1 trials
- Refractory Glioblastoma1 trials
- Refractory Grade 3b Follicular Lymphoma5 trials
- Refractory Head and Neck Squamous Cell Carcinoma2 trials
- Refractory Hematologic Malignancy2 trials
- Refractory Hepatoblastoma1 trials
- Refractory Hepatocellular Carcinoma1 trials
- Refractory Hepatosplenic T-Cell Lymphoma2 trials
- Refractory High Grade B-Cell Lymphoma4 trials
- Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements2 trials
- Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements1 trials
- Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified1 trials
- Refractory High Risk Myelodysplastic Syndrome1 trials
- Refractory Hodgkin Lymphoma3 trials
- Refractory Hurthle Cell Thyroid Cancer1 trials
- Refractory Hyperlipidemia1 trials
- Refractory Hypopharyngeal Squamous Cell Carcinoma1 trials
- Refractory Idiopathic Membranous Nephropathy1 trials
- Refractory Immune Cytopenias1 trials
- Refractory Juvenile Myelomonocytic Leukemia1 trials
- Refractory Kidney Medullary Carcinoma1 trials
- Refractory Langerhans Cell Histiocytosis
- Refractory Large B-cell Lymphoma1 trials
- Refractory Laryngeal Squamous Cell Carcinoma1 trials
- Refractory Leiomyosarcoma1 trials
- Refractory Leukemia1 trials
- Refractory Lung Non-Small Cell Carcinoma2 trials
- Refractory Lupus Nephritis2 trials
- Refractory Lymphoblastic Lymphoma
- Refractory Lymphoma3 trials
- Refractory Lymphoplasmacytic Lymphoma1 trials
- Refractory Malignant Brain Neoplasm1 trials
- Refractory Malignant Female Reproductive System Neoplasm1 trials
- Refractory Malignant Germ Cell Tumor1 trials
- Refractory Malignant Neoplasm1 trials
- Refractory Malignant Solid Neoplasm8 trials
- Refractory Mantle Cell Lymphoma7 trials
- Refractory Marginal Zone Lymphoma4 trials
- Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma3 trials
- Refractory Melanoma3 trials
- Refractory Meningioma1 trials
- Refractory Merkel Cell Carcinoma1 trials
- Refractory Metastatic Colorectal Cancer2 trials
- Refractory Microsatellite Stable Colorectal Carcinoma1 trials
- Refractory Mixed Lineage Leukemia1 trials
- Refractory Mixed Phenotype Acute Leukemia2 trials
- Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma1 trials
- Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder1 trials
- Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy1 trials
- Refractory Multiple Myeloma20 trials
- Refractory Multiple Myeloma (RRMM)1 trials
- Refractory Mycosis Fungoides3 trials
- Refractory Myelodysplastic Syndrome5 trials
- Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia
- Refractory Myelodysplastic Syndromes1 trials
- Refractory Myelodysplastic/Myeloproliferative Neoplasm2 trials
- Refractory Myeloid Neoplasm1 trials
- Refractory Myeloproliferative Neoplasm1 trials
- Refractory Myxoid Liposarcoma1 trials
- Refractory Natural Killer/T-cell Lymphoma1 trials
- Refractory Neoplasm1 trials
- Refractory Neuroblastoma4 trials
- Refractory Nodal Marginal Zone Lymphoma1 trials
- Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma1 trials
- Refractory Non-Hodgkin Lymphoma8 trials
- Refractory Non-Small Cell Lung Cancer1 trials
- Refractory or Unexplained Chronic Cough
- Refractory Oral Cavity Squamous Cell Carcinoma1 trials
- Refractory Oropharyngeal Squamous Cell Carcinoma1 trials
- Refractory Osteosarcoma3 trials
- Refractory Ovarian Carcinoma1 trials
- Refractory Ovarian Clear Cell Adenocarcinoma1 trials
- Refractory Ovarian High Grade Serous Adenocarcinoma1 trials
- Refractory Pain1 trials
- Refractory Pancreatic Adenocarcinoma1 trials
- Refractory Pancreatic Carcinoma
- Refractory Pancreatic Ductal Adenocarcinoma1 trials
- Refractory Pediatric AML1 trials
- Refractory Peripheral Primitive Neuroectodermal Tumor1 trials
- Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified3 trials
- Refractory Plasma Cell Myeloma5 trials
- Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder1 trials
- Refractory Primary Amyloidosis2 trials
- Refractory Primary Central Nervous System Lymphoma1 trials
- Refractory Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma1 trials
- Refractory Primary Cutaneous Gamma-Delta T-Cell Lymphoma1 trials
- Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma2 trials
- Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma1 trials
- Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma2 trials
- Refractory Primary Mediastinal Large B-Cell Lymphoma4 trials
- Refractory Primary Peritoneal Carcinoma1 trials
- Refractory Renal Cell Carcinoma1 trials
- Refractory Rhabdoid Tumor2 trials
- Refractory Rhabdomyosarcoma1 trials
- Refractory Rheumatoid Arthritis (RA)1 trials
- Refractory Round Cell Liposarcoma1 trials
- Refractory Sarcoma1 trials
- Refractory Secondary Acute Myeloid Leukemia1 trials
- Refractory Seizures1 trials
- Refractory Severe Aplastic Anemia1 trials
- Refractory Skin Squamous Cell Carcinoma1 trials
- Refractory Small Lymphocytic Lymphoma5 trials
- Refractory Soft Tissue Sarcoma2 trials
- Refractory Solid Tumor2 trials
- Refractory Splenic Marginal Zone Lymphoma1 trials
- Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma1 trials
- Refractory Synovial Sarcoma1 trials
- Refractory Systemic Lupus Erythematosus3 trials
- REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS1 trials
- Refractory Systemic Sclerosis1 trials
- Refractory T Acute Lymphoblastic Leukemia1 trials
- Refractory T Lymphoblastic Lymphoma1 trials
- Refractory T-Cell Non-Hodgkin Lymphoma1 trials
- Refractory Transformed1 trials
- Refractory Transformed B-cell Non-Hodgkin Lymphoma2 trials
- Refractory Transformed B-Cell Non-Hodgkin Lymphoma3 trials
- Refractory Transformed Chronic Lymphocytic Leukemia5 trials
- Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma1 trials
- Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma2 trials
- Refractory Transformed Non-Hodgkin Lymphoma4 trials
- Refractory Triple-Negative Breast Carcinoma1 trials
- Refractory Tumor1 trials
- Refractory Undifferentiated Pleomorphic Sarcoma1 trials
- Refractory Urothelial Carcinoma2 trials
- Refractory/Relapsed Acute Myeloid Leukaemia1 trials
- Refractory/Relapsed Systemic Lupus Erythematosus1 trials
- Refsum Disease2 trials
- Regional Anaesthesia
- Regional Anesthesia3 trials
- Regional Anesthesia Success
- Regional Neuroblastoma1 trials
- Regorafenib1 trials
- Rehabilitation9 trials
- Reintegration1 trials
- Rejection; Transplant, Liver1 trials
- Relapse5 trials
- Relapse Diffuse Large B Cell Lymphoma1 trials
- Relapse Multiple Myeloma4 trials
- Relapse Remitting Multiple Sclerosis1 trials
- Relapse/Recurrence3 trials
- Relapsed2 trials
- Relapsed / Refractory AML1 trials
- Relapsed /Refractory DLBCL1 trials
- Relapsed Acute Biphenotypic Leukemia1 trials
- Relapsed Acute Lymphoblastic Leukemia (ALL)1 trials
- Relapsed Acute Myelogenous Leukemia (AML)1 trials
- Relapsed Acute Myeloid Leukemia5 trials
- Relapsed Adult ALL2 trials
- Relapsed Adult AML2 trials
- Relapsed AL Amyloidosis1 trials
- Relapsed ALL, Adult1 trials
- Relapsed and Refractory B-cell Non-Hodgkin Lymphoma1 trials
- Relapsed and Refractory Hematological Malignancies1 trials
- Relapsed and Refractory Multiple Myeloma2 trials
- Relapsed and Refractory Multiple Myeloma (RRMM)
- Relapsed and/or Refractory B-cell Lymphoma1 trials
- Relapsed and/or Refractory Mature T Cell Malignancy1 trials
- Relapsed and/or Refractory Multiple Myeloma2 trials
- Relapsed and/or Refractory Multiple Myeloma (RRMM)1 trials
- Relapsed B-cell NHL1 trials
- Relapsed B-Cell Non Hodgkin Lymphoma1 trials
- Relapsed B-cell Non-Hodgkin Lymphoma1 trials
- Relapsed B-Cell Non-Hodgkin Lymphoma2 trials
- Relapsed Biphenotypic Leukemia1 trials
- Relapsed Cancer6 trials
- Relapsed Chronic Lymphocytic Leukemia3 trials
- Relapsed Chronic Myelomonocytic Leukemia1 trials
- Relapsed Classical Hodgkin Lymphoma1 trials
- Relapsed CLL1 trials
- Relapsed Diffuse Large B Cell Lymphoma2 trials
- Relapsed Diffuse Large B-cell Lymphoma1 trials
- Relapsed Diffuse Large B-Cell Lymphoma1 trials
- Relapsed Diffuse Large B-cell Lymphoma (DLBCL)1 trials
- Relapsed Ewing Sarcoma2 trials
- Relapsed Follicular Lymphoma2 trials
- Relapsed Hematologic Malignancy2 trials
- Relapsed Hodgkin's Disease, Adult1 trials
- Relapsed Large B-cell Lymphoma1 trials
- Relapsed Leukemia1 trials
- Relapsed Lymphoma1 trials
- Relapsed Malignant Solid Neoplasm1 trials
- Relapsed Marginal Zone Lymphoma1 trials
- Relapsed Meningioma1 trials
- Relapsed Mixed Lineage Leukemia1 trials
- Relapsed Mixed Phenotype Acute Leukemia1 trials
- Relapsed Multiple Myeloma3 trials
- Relapsed Myelodysplastic Syndrome1 trials
- Relapsed Myelodysplastic Syndromes1 trials
- Relapsed Myeloid Neoplasm1 trials
Analyze any biotech with AI
Full pipeline, catalysts, financials & FDA data — with evidence-backed multi-agent analysis.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company